{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:16:10Z","timestamp":1767914170148,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/eye.2016.23","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T10:31:24Z","timestamp":1457087484000},"page":"718-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections"],"prefix":"10.1038","volume":"30","author":[{"given":"M","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y J","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"issue":"13","key":"BFeye201623_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW . Diabetic retinopathy. N Engl J Med 2012; 366 (13): 1227\u20131239.","journal-title":"N Engl J Med"},{"issue":"4","key":"BFeye201623_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118 (4): 445\u2013450.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"BFeye201623_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ophtha.2008.12.024","volume":"116","author":"N Arimura","year":"2009","unstructured":"Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y et al. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology 2009; 116 (5): 921\u2013926.","journal-title":"Ophthalmology"},{"issue":"2","key":"BFeye201623_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/bjo.2010.181222","volume":"96","author":"H Funatsu","year":"2012","unstructured":"Funatsu H, Noma H, Mimura T, Eguchi S . Vitreous inflammatory factors and macular oedema. Br J Ophthalmol 2012; 96 (2): 302\u2013304.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"BFeye201623_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","volume":"116","author":"H Funatsu","year":"2009","unstructured":"Funatsu H, Noma H, Mimura T, Eguchi S, Hori S . Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 2009; 116 (1): 73\u201379.","journal-title":"Ophthalmology"},{"issue":"10","key":"BFeye201623_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","volume":"120","author":"DM Brown","year":"2013","unstructured":"Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 2013; 120 (10): 2013\u20132022.","journal-title":"Ophthalmology"},{"issue":"10","key":"BFeye201623_CR7","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 2014; 121 (10): 1904\u20131914.","journal-title":"Ophthalmology"},{"issue":"12","key":"BFeye201623_CR8","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","volume":"121","author":"MC Gillies","year":"2014","unstructured":"Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J et al. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 2014; 121 (12): 2473\u20132481.","journal-title":"Ophthalmology"},{"issue":"4","key":"BFeye201623_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/IAE.0b013e3182a48958","volume":"34","author":"R Lazic","year":"2014","unstructured":"Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N et al. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina 2014; 34 (4): 719\u2013724.","journal-title":"Retina"},{"issue":"3","key":"BFeye201623_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archophthalmol.2010.21","volume":"128","author":"JA Haller","year":"2010","unstructured":"Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010; 128 (3): 289\u2013296.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201623_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OPTH.S48364","volume":"7","author":"E Pacella","year":"2013","unstructured":"Pacella E, Vestri AR, Muscella R, Carbotti MR, Castellucci M, Coi L et al. Preliminary results of an intravitreal dexamethasone implant (Ozurdex(R)) in patients with persistent diabetic macular edema. Clin Ophthalmol 2013; 7: 1423\u20131428.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"BFeye201623_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/IAE.0b013e318206d18c","volume":"31","author":"DS Boyer","year":"2011","unstructured":"Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011; 31 (5): 915\u2013923.","journal-title":"Retina"},{"issue":"6","key":"BFeye201623_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/IAE.0000000000000035","volume":"34","author":"JB Jonas","year":"2014","unstructured":"Jonas JB, Forster TM, Steinmetz P, Schlichtenbrede FC, Harder BC . Choroidal thickness in age-related macular degeneration. Retina 2014; 34 (6): 1149\u20131155.","journal-title":"Retina"},{"issue":"5","key":"BFeye201623_CR14","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1167\/iovs.12-11503","volume":"54","author":"JT Kim","year":"2013","unstructured":"Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH . Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci 2013; 54 (5): 3378\u20133384.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"BFeye201623_CR15","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1167\/iovs.13-12231","volume":"54","author":"M Kim","year":"2013","unstructured":"Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC . Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci 2013; 54 (9): 6033\u20136039.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"BFeye201623_CR16","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1167\/iovs.14-14188","volume":"55","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Otsuka H, Shirasawa M, Kakiuchi N et al. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2014; 55 (6): 3979\u20133985.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"BFeye201623_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archopht.116.5.589","volume":"116","author":"J Cao","year":"1998","unstructured":"Cao J, McLeod S, Merges CA, Lutty GA . Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 1998; 116 (5): 589\u2013597.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"BFeye201623_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1055\/s-2008-1050772","volume":"189","author":"H Freyler","year":"1986","unstructured":"Freyler H, Prskavec F, Stelzer N . Diabetic choroidopathy\u2014a retrospective fluorescein angiography study. Preliminary report. Klin Monbl Augenheilkd 1986; 189 (2): 144\u2013147.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"12","key":"BFeye201623_CR19","doi-asserted-by":"publisher","first-page":"e83494","DOI":"10.1371\/journal.pone.0083494","volume":"8","author":"R Hua","year":"2013","unstructured":"Hua R, Liu L, Wang X, Chen L . Imaging evidence of diabetic choroidopathy in vivo: angiographic pathoanatomy and choroidal-enhanced depth imaging. PLoS One 2013; 8 (12): e83494.","journal-title":"PLoS One"},{"issue":"3","key":"BFeye201623_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/IAE.0B013E31822F5678","volume":"32","author":"CV Regatieri","year":"2012","unstructured":"Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS . Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 2012; 32 (3): 563\u2013568.","journal-title":"Retina"},{"key":"BFeye201623_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/OPTH.S59395","volume":"8","author":"E Unsal","year":"2014","unstructured":"Unsal E, Eltutar K, Zirtiloglu S, Dincer N, Ozdogan Erkul S, Gungel H . Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 2014; 8: 637\u2013642.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"BFeye201623_CR22","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ajo.2014.08.001","volume":"158","author":"BS Gerendas","year":"2014","unstructured":"Gerendas BS, Waldstein SM, Simader C, Deak G, Hajnajeeb B, Zhang L et al. Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am J Ophthalmol 2014; 158 (5): 1039\u20131048.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"BFeye201623_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ajo.2014.06.006","volume":"158","author":"G Yiu","year":"2014","unstructured":"Yiu G, Manjunath V, Chiu SJ, Farsiu S, Mahmoud TH . Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema. Am J Ophthalmol 2014; 158 (4): 745\u2013751 e742.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"BFeye201623_CR24","first-page":"642","volume":"147","author":"DS McLeod","year":"1995","unstructured":"McLeod DS, Lefer DJ, Merges C, Lutty GA . Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147 (3): 642\u2013653.","journal-title":"Am J Pathol"},{"issue":"4","key":"BFeye201623_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0161-6420(85)34013-7","volume":"92","author":"AA Hidayat","year":"1985","unstructured":"Hidayat AA, Fine BS . Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 1985; 92 (4): 512\u2013522.","journal-title":"Ophthalmology"},{"issue":"8","key":"BFeye201623_CR26","first-page":"299","volume":"20","author":"AW Fryczkowski","year":"1988","unstructured":"Fryczkowski AW, Sato SE, Hodes BL . Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol 1988; 20 (8): 299\u2013305.","journal-title":"Ann Ophthalmol"},{"issue":"8","key":"BFeye201623_CR27","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1248\/bpb.31.1541","volume":"31","author":"K Wang","year":"2008","unstructured":"Wang K, Wang Y, Gao L, Li X, Li M, Guo J . Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression. Biol Pharm Bull 2008; 31 (8): 1541\u20131546.","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"BFeye201623_CR28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1167\/iovs.04-0905","volume":"46","author":"H Tamura","year":"2005","unstructured":"Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 2005; 46 (4): 1440\u20131444.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"BFeye201623_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1046\/j.0022-3042.2001.00740.x","volume":"80","author":"DA Antonetti","year":"2002","unstructured":"Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr . Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 2002; 80 (4): 667\u2013677.","journal-title":"J Neurochem"},{"issue":"1","key":"BFeye201623_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cvr\/cvn231","volume":"81","author":"Y Liu","year":"2009","unstructured":"Liu Y, Mladinov D, Pietrusz JL, Usa K, Liang M . Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res 2009; 81 (1): 140\u2013147.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"BFeye201623_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","volume":"107","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Gaynor RB . Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107 (2): 135\u2013142.","journal-title":"J Clin Invest"},{"issue":"12","key":"BFeye201623_CR32","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1167\/iovs.12-10464","volume":"53","author":"M Kim","year":"2012","unstructured":"Kim M, Kim SS, Kwon HJ, Koh HJ, Lee SC . Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci 2012; 53 (12): 7710\u20137717.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye201623_CR33","first-page":"1734","volume":"19","author":"N Dong","year":"2013","unstructured":"Dong N, Xu B, Wang B, Chu L . Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis 2013; 19: 1734\u20131746.","journal-title":"Mol Vis"},{"issue":"12","key":"BFeye201623_CR34","doi-asserted-by":"publisher","first-page":"e8158","DOI":"10.1371\/journal.pone.0008158","volume":"4","author":"T Yoshimura","year":"2009","unstructured":"Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009; 4 (12): e8158.","journal-title":"PLoS One"},{"issue":"1","key":"BFeye201623_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005; 243 (1): 3\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"BFeye201623_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3109\/02713683.2010.510257","volume":"35","author":"IK Oh","year":"2010","unstructured":"Oh IK, Kim SW, Oh J, Lee TS, Huh K . Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 2010; 35 (12): 1116\u20131127.","journal-title":"Curr Eye Res"},{"issue":"4","key":"BFeye201623_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/IAE.0b013e3182a48917","volume":"34","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Otsuka H, Sonoda Y . Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema. Retina 2014; 34 (4): 741\u2013748.","journal-title":"Retina"},{"issue":"5","key":"BFeye201623_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109 (5): 920\u2013927.","journal-title":"Ophthalmology"},{"issue":"5","key":"BFeye201623_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","volume":"136","author":"DM Moshfeghi","year":"2003","unstructured":"Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136 (5): 791\u2013796.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"BFeye201623_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","volume":"101","author":"GB Jaissle","year":"2004","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt KU . Ocular side effects and complications of intravitreal triamcinolone acetonide injection. Ophthalmologe 2004; 101 (2): 121\u2013128.","journal-title":"Ophthalmologe"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201623","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:28:35Z","timestamp":1684430915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFeye201623"],"URL":"https:\/\/doi.org\/10.1038\/eye.2016.23","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}